Aytu BioScience Inc. received subscriptions for a private placement of about $11.5 million of equity units.
Class A units consisting of 1 common share and a warrant to buy 1.5 common shares were sold at 15 cents per unit. Class B units consisting of 1 share of series A preferred stock and warrants to buy 1.5 common shares for each common share into which the series A preferred stock is convertible were sold at $1,000 per unit.
The exercise price of the warrants, which terminate in five years, is 18 cents per share, subject to adjustment.
The company expects to use proceeds for sales and marketing expenses to further advance the commercialization of Natesto and for working capital and general corporate purposes.
Joseph Gunnar & Co. LLC acted as lead placement agent and Fordham Financial Management Inc. acted as co-placement agent for the transaction.